Answers are grounded in this paper and cite their sources.
The main objective of my research work is to develop a bilayer tablet of Probenecid, in which one layer is immediate layer for immediate action and second layer is the sustain release layer for maintaining the dose of the drug. Probenecid is frequently administered up to 3 times in a day. So, the reducing dosing frequency by sustained release tablet.
No takes yet. Share an insight, caveat, or question.
Wagh et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: